Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?

This study has been completed.
Information provided by:
Sheba Medical Center Identifier:
First received: December 22, 2005
Last updated: December 18, 2007
Last verified: December 2007
Evaluating the prevalence and characteristics of obsessive-compulsive (OC) symptoms in patients with chronic schizophrenia

Obsessive Compulsive Disorder

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by Sheba Medical Center:

Estimated Study Completion Date: March 2007

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Genders Eligible for Study:   Both

Inclusion Criteria:

  • Schizophrenic patients
  • Schizophrenic patients with OCD

Exclusion Criteria:

  • Organic problems
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00269464

Sponsors and Collaborators
Sheba Medical Center
Principal Investigator: Joseph Zohar, MD Tel Aviv University
  More Information Identifier: NCT00269464     History of Changes
Other Study ID Numbers: SHEBA-03-8888-JZ-CTIL 
Study First Received: December 22, 2005
Last Updated: December 18, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Compulsive Behavior
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders
Personality Disorders
Anxiety Disorders
Impulsive Behavior processed this record on October 21, 2016